Literature DB >> 16897814

Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K.

Rebecca J Benson1, Bruce S Hostager, Gail A Bishop.   

Abstract

The activation molecule CD40 and the death receptor CD95/Fas play important roles in regulating B cells so that effective antimicrobial immunity occurs without autoimmunity. CD40 signaling increases CD95 expression, sensitizing cells to apoptosis, but sustained CD40 signals rescue B cells from CD95 killing. Here we describe a mechanism of early CD40-mediated rescue from CD95-induced apoptosis in B cells. Maximal rescue was achieved when CD40 signals were given within 1-2 h of initiating CD95 apoptosis. CD40 signaling did not block association of Fas-associated death domain-containing protein with CD95, but decreased CD95-induced activation of caspases 3 and 8. Rapid CD40 rescue did not require NF-kappaB activation and was independent of de novo protein synthesis, but was dependent upon active PI3 K. Signaling via a CD40 mutant that does not bind TNFR-associated factor (TRAF)1, TRAF2, and TRAF3 rescued B cells from CD95-induced apoptosis. TRAF1/2/3-independent rescue was confirmed in B cell lines made deficient in these TRAF molecules by gene targeting. In contrast, CD40 rescue was completely abrogated in TRAF6-deficient B cells, which showed reduced activation of Akt in response to CD40 engagement. These results reveal a new rapid mechanism to balance B cell activation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897814     DOI: 10.1002/eji.200535483

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

Review 2.  Roles of TRAF6 in CD40 signaling.

Authors:  Bruce S Hostager
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells.

Authors:  Frank Secreto; Michelle Manske; Tammy Price-Troska; Steven Ziesmer; Lucy S Hodge; Stephen M Ansell; James R Cerhan; Anne J Novak
Journal:  Leuk Lymphoma       Date:  2014-02-24

4.  A novel TNF receptor-associated factor 6 binding domain mediates NF-kappa B signaling by the common cytokine receptor beta subunit.

Authors:  Mark B Meads; Zhi-Wei Li; William S Dalton
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

5.  Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation.

Authors:  F Palacios; C Abreu; D Prieto; P Morande; S Ruiz; T Fernández-Calero; H Naya; G Libisch; C Robello; A I Landoni; R Gabus; G Dighiero; P Oppezzo
Journal:  Leukemia       Date:  2014-05-14       Impact factor: 11.528

Review 6.  Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.

Authors:  Jason R Westin
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-02-07

7.  HOIL-1L interacting protein (HOIP) as an NF-kappaB regulating component of the CD40 signaling complex.

Authors:  Bruce S Hostager; Daniel K Fox; Douglas Whitten; Curtis G Wilkerson; Betty A Eipper; Victor P Francone; Paul B Rothman; John D Colgan
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

8.  A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling.

Authors:  Joanne M Hildebrand; Zhenghua Luo; Michelle K Manske; Tammy Price-Troska; Steven C Ziesmer; Wai Lin; Bruce S Hostager; Susan L Slager; Thomas E Witzig; Stephen M Ansell; James R Cerhan; Gail A Bishop; Anne J Novak
Journal:  J Exp Med       Date:  2010-11-01       Impact factor: 14.307

9.  A novel polymorphism of the human CD40 receptor with enhanced function.

Authors:  Anna L Peters; Robert M Plenge; Robert R Graham; David M Altshuler; Kathy L Moser; Patrick M Gaffney; Gail A Bishop
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

10.  A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation.

Authors:  Mamta Gupta; Stacey R Dillon; Steven C Ziesmer; Andrew L Feldman; Thomas E Witzig; Stephen M Ansell; James R Cerhan; Anne J Novak
Journal:  Blood       Date:  2009-03-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.